Titel

Merkliste
1 Ergebnisse

Impact of the treatment crossover design on comparative eff..:

Feliciano, Josephine Louella ; McLoone, Dylan ; Xu, Yingxin...
https://discovery.ucl.ac.uk/id/eprint/10169524/1/Impact%20of%20the%20treatment%20crossover%20design%20on%20comparative%20efficacy%20in%20EMPOWER-Lung%201%20Cemiplimab%20monotherapy%20as%20first-line%20trea.pdf. , 2023

Link: https://discovery.ucl.ac.uk/id/eprint/10169524/1/Impac..

RT Journal
T1 <Title>Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10169524&Exemplar=1&LAN=DE
				
A1 Feliciano, Josephine Louella
A1 McLoone, Dylan
A1 Xu, Yingxin
A1 Quek, Ruben GW
A1 Kuznik, Andreas
A1 Pouliot, Jean-Francois
A1 Gullo, Giuseppe
A1 Rietschel, Petra
A1 Guyot, Patricia
A1 Konidaris, Gerasimos
A1 Chan, Keith
A1 Keeping, Sam
A1 Wilson, Florence R
A1 Freemantle, Nick
PB FRONTIERS MEDIA SA
YR 2023
K1 non-small cell lung cancer
K1 first-line treatment
K1 cemiplimab
K1 crossover design
K1 EMPOWER-lung 1
K1 chemotherapy
JF https://discovery.ucl.ac.uk/id/eprint/10169524/1/Impact%20of%20the%20treatment%20crossover%20design%20on%20comparative%20efficacy%20in%20EMPOWER-Lung%201%20Cemiplimab%20monotherapy%20as%20first-line%20trea.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10169524/1/Impact%20of%20the%20treatment%20crossover%20design%20on%20comparative%20efficacy%20in%20EMPOWER-Lung%201%20Cemiplimab%20monotherapy%20as%20first-line%20trea.pdf
DO https://discovery.ucl.ac.uk/id/eprint/10169524/1/Impact%20of%20the%20treatment%20crossover%20design%20on%20comparative%20efficacy%20in%20EMPOWER-Lung%201%20Cemiplimab%20monotherapy%20as%20first-line%20trea.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)